Immunovant Q2'26 Earnings Preview Lists Revenue Estimate
Immunovant is scheduled to report Q2'26 results on November 9 before the market opens. Revenue is estimated at zero, with EPS anticipated at $(0.74).
IMVT (Immunovant, Inc.) is set to announce its Q2'26 results on November 09, before the market opens. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).For Q2'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.74) USD. Learn more details at IMVT Finan…